ArticleCentral European journal of urology2018

Efficacy and safety of Afalaza in men with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial.

Dmitry Pushkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.